ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Baseline Levels and Early Post-Transplant Kinetics of Donor-Derived Cell-Free DNA Following Liver Transplantation

S. Florman1, D. Axelrod2, J. Miles3, E. Vaskova3, D. Kilam3, K. Dhanireddy4, V. Subramanian4

1Mount Sinai Medical Center, New York, NY, 2University of Iowa, Iowa City, IA, 3CareDx, South San Francisco, CA, 4Tampa General Hospital, Tampa, FL

Meeting: 2022 American Transplant Congress

Abstract number: 1575

Keywords: Graft function, Liver transplantation, Rejection

Topic: Basic Science » Basic Clinical Science » 17 - Biomarkers: Clinical Outcomes

Session Information

Session Name: Biomarkers: Clinical Outcomes

Session Type: Poster Abstract

Date: Tuesday, June 7, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Non-invasive biomarkers in liver transplant (LT) are needed to improve detection of allograft injury in routine surveillance and during immunosuppression modulation, prior to the development of graft dysfunction. Donor-derived cell-free DNA (dd-cfDNA) as an injury marker can quantify subclinical inflammation and molecular injury in solid organ transplant (SOT) recipients. Here, we describe the baseline levels and early post-transplant (PT) kinetics of dd-cfDNA in LT.

*Methods: LT recipients from the prospective, multicenter Molecular Assessment and Profiling of Liver transplant rEcipients (MAPLE) study (NCT 04793360) were examined. All patients had serial dd-cfDNA (AlloSure; CareDx) levels monitored PT in tandem with routine surveillance, beginning as early as day 1 post-operatively.

*Results: 31 stable LT recipients were identified, with 114 dd-cfDNA draws within 6 months PT. Stability was defined as absence of graft dysfunction (>50% change in LFTs), acute rejection or infection. Patients included both deceased and living donor LTs (Table 1). dd-cfDNA was significantly elevated in the first week PT (median 22.3%, IQR 12.91-33.38%) and declined rapidly over two weeks in stable patients (Figure 1A). Living donor LT showed a significant decline in median dd-cfDNA between week 1 and 2 PT (33.8% and 4.6% respectively, p=0.01). The median level of dd-cfDNA in stable LT recipients (n=31) >14 days after LT was 2.5% (IQR 1.19-6.67%, Figure 1B).

*Conclusions: LT recipients demonstrate an exponential decay of dd-cfDNA following transplantation, which may reflect recovery from ischemia reperfusion injury. This trend appeared accelerated in living donor LT recipients. After 14 days PT, LT recipients have low levels of circulating dd-cfDNA in the absence of rejection, graft dysfunction or infection. Although the absolute percentage of dd-cfDNA in stable LT recipients differ from other organs, the pattern of distribution remains consistent. The MAPLE study will continue to assess the ability of cfDNA to identify alloimmune injury non-invasively after LT.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Florman S, Axelrod D, Miles J, Vaskova E, Kilam D, Dhanireddy K, Subramanian V. Baseline Levels and Early Post-Transplant Kinetics of Donor-Derived Cell-Free DNA Following Liver Transplantation [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/baseline-levels-and-early-post-transplant-kinetics-of-donor-derived-cell-free-dna-following-liver-transplantation/. Accessed May 29, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences